Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Cagrilintide for Sale > CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss
CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss buy - large image1
CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss buy - image1
CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss buy - image2
CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss buy - image3
CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss buy - image4
CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss buy - image5
CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss buy - image6

CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss

TDS 59 Inquiries

Unit Price:

$86/UNIT FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Brand:

DX

Packaging:

10mg/vial,10vials/box

Price valid (until):

2029-11-22

Company Type:
Trader
Location:
China
Qualification:
Main Products:

GLP-1,trizepatide,Semaglutide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Name:Nancy
    WhatsApp:+86 19831965506
    Email Address:nancy@xtdaxiang.cn


      Product Detail  


    Cagrilintideis an amylin-analog, now being developed in combination with the GLP-1 semaglutide to achieve sustained weight loss in persons with overweight and obesity. Amylin, released with insu from beta cells in the pancreas, induces its satiating effect via both the homoeostatic and hedonic regions of the brain. Semaglutide reduces appetite via GLP-1 receptors in the hypothalamus and increases the production of insu, and reduces glucagon secretion, delaying gastric emptying. These separate, but related mechanisms of action of an amylin-analog . Given the heterogeneity and complex pathogenesis of obesity, combination therapy with multiple pathophysiological targets is a logical approach to increasing weight loss response with pharmacotherapy. Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management. Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 1 Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 2

    Items Specifications
    Name    Cagrelinide
    Solubility Dissolved in dimethyl sulfoxide
    Storage condition  -20°C


    Appearance: Powder
    Purity: >98% (or refer to the Certificate of Analysis)
    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
    Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
    Solubility: To be determined
    Shelf Life: >2 years if stored properly
    Drug Formulation: To be determined
    Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).


    Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 3

    Product Application   
    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1  semaglutide to achieve sustained weight loss in persons with overweight and obesity. 
    Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management.

    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 semaglutide to achieve sustained weight loss in persons with overweight and obesity.

    Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management.Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 4

    When storing peptides, remember to:
    • Store peptide in a cold, dry, dark place
    • Avoid repeated freezing and thawing of peptide
    • Avoid overexposure to the air
    • Avoid light exposure
    • Avoid storing peptides in solution long term
    • Aliquot peptide according to experimental requirements

    Why choose us?


    Our Advantages:
    1.High quality with competitive price.
    2.All purity>99%.
    3. We are manufacturer and can provide high quality products with factory price.
    Fast and safe delivery:
    1. Parcel can be sent out in 48 hours after payment tracking number available.
    2. Secure and discreet shipment verious transportation methods for your choice.
    3. Customs pass rate >99%.

    Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 5

    FAQ:
    Q1:  Can I get free samples?
    A: Sure, we can provide a free sample, but client need afford the shipping fee.
    Q2:  How do I know you can delivery success?
    A: We will use discreet packing and door to door safe delivery method.
    Q3:  What's your MOQ?
    A: According to different products to decide, like may be 1g or 10g.
    Q4:  How to contact us ?
    A: You can choose your interested products and send inquiry to Us.

    Company profile


    Daxiang Technology Co., Ltd., is a high-tech enterprise focusing on the research, development and production of peptide products. The company was established in recent years and is committed to applying advanced biotechnology to the health industry to meet the market's demand for high-quality, high-efficiency peptide products.​

    As a leading peptide manufacturer, Daxiang Technology has a R&D team composed of senior scientists and engineers, which continues to explore and innovate, and is committed to developing safer, more effective, and more market-competitive peptide products. The company's main products cover but are not limited to pharmaceutical grade, food grade and cosmetic grade and other fields, and are widely used in many aspects such as health care, disease prevention, beauty and skin care.​

    In terms of production technology, Daxiang Technology adopts internationally advanced production equipment and technology to ensure that every aspect of the product, from raw material selection, production and processing to finished product packaging, strictly follows relevant national standards and specifications to ensure product quality and safety. At the same time, the company has also established a complete quality management system and after-sales service system to provide customers with all-round, one-stop service support.​

    Daxiang Technology adheres to the corporate philosophy of "technology leads health, quality creates the future" and always adheres to the development path of people-oriented and technological innovation. The company not only focuses on product quality and innovation, but also actively fulfills its social responsibilities and is committed to promoting the development and progress of the health industry.​

    In the future,Daxiang Technology Co., Ltd. will continue to delve into the field of peptide product research and development, continue to explore and make breakthroughs, and strive to become a leader in the global peptide industry and make greater contributions to human health.

    Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 6 Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 7 Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 8 Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 9 Shop CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss-Detailed Image 10

    ECHEMI Editorial Reference
    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia[1-2].

    Certificates
    • CAS 1415456-99-3 Cagrilintide Peptides 99% Purity 5mg 10mg Cosmetic Peptides for Weight Loss Certificates 1 TDS

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,trizepatide,Semaglutide,Retatrutide

    Location:

    Room 2012, No. 6-143, Section 2, Shanghai Road, Guta District, Jinzhou City, Liaoning Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    2

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2024

     Daxiang Technology Co., Ltd. is a leading manufacturer and global supplier of high-quality peptide-based pharmaceuticals and fine chemicals. We specialize in the research, development, and production of diverse peptide compounds that meet the rigorous standards of the international pharmaceutical and biotechnology industries.
    Our commitment to excellence is reflected in our strictly GMP-compliant manufacturing facilities, ensuring the highest levels of quality, purity, and consistency in every product.
    We always adhere to market demand as our guide, and continually develop and synthesize new high-tech chemical products.
    Leveraging our global footprint, our products are exported to Europe, the Americas, Southeast Asia, Africa, and other regions, serving customers worldwide.
    Driven by innovation and a customer-centric philosophy, Daxiang Technology Co., Ltd. is dedicated to being your trusted partner for premium peptide solutions, supporting advancements in healthcare and technology worldwide.

  • Inquiry History
    59 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.